Warnerville veteran is honored by state Senate
A Schoharie County military veteran has been added to the New York State Senate Veterans' Hall of Fame.
Sen. Peter Oberacker announced Tuesday that he recognized Richard 'Bunk' Bingham, a retired Army first sergeant from Warnerville, as the 2025 inductee for the 51st Senate District. "This prestigious honor celebrates a lifetime of selfless military service, leadership and unwavering commitment to our nation," a news release from Oberacker's office stated.
'It is my distinct honor today to celebrate a true American hero whose life has been defined by a selfless and unwavering commitment to our nation,' Oberacker said. '1st Sgt. Bingham answered the call to duty during one of the most turbulent times in American history and has never stopped giving back.'
Bingham's military service began April 23, 1968, when he was drafted into the U.S. Army and deployed to Vietnam with the 1st Aviation Brigade, the release stated. He served as a motorpool sergeant and returned home in December 1969. In 1977, he resumed service with the 414th Civil Affairs Company in Utica, later joining the 426th Civil Affairs Company in California as a military police supervisor. After returning to New York, he dedicated seven years to mentoring recruits as a basic training first sergeant with the 1165th Training Unit, according to the release.
During his time in uniform, Bingham earned numerous honors, including the National Defense Service Medal, Vietnam Service Medal, Vietnam Campaign Medal, Army Commendation Medal and the Humanitarian Service Medal, the release stated. He retired with the rank of first sergeant in 2007, "closing a distinguished military career marked by humility, courage and an everlasting dedication."
'To Bunk, wearing the uniform was never just an obligation, but a sacred privilege,' Oberacker said. 'His story is an inspiration to me personally and to all who know him. We are proud to honor his service and the values he continues to embody."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
37 minutes ago
- Boston Globe
Today in History: June 21, US Constitution becomes law
Advertisement In 1834, Cyrus Hall McCormick received a patent for his mechanical reaper. In 1893, the first Ferris wheel opened to the public as part of the Chicago World's Fair. In 1942, an Imperial Japanese submarine fired shells at Fort Stevens on the Oregon coast, but caused little damage. In 1954, scientists of the American Cancer Society presented a study to a meeting of the American Medical Association in San Francisco, Calif., which found that men who regularly smoked cigarettes died, particularly from lung cancer, at a considerably higher rate than non-smokers. In 1964, civil rights activists James Chaney, Andrew Goodman, and Michael Schwerner were murdered in Neshoba County, Miss. Their bodies were found buried in an earthen dam six weeks later. (Forty-one years later, on this date in 2005, Edgar Ray Killen, an 80-year-old former Ku Klux Klansman, was found guilty of manslaughter in their deaths; he was sentenced to 60 years in prison, where he died in January 2018.) Advertisement In 1982, a jury in Washington, D.C., found John Hinckley Jr. not guilty by reason of insanity in the shootings of President Ronald Reagan, Press Secretary James Brady, Washington D.C. police officer Thomas Delahanty, and Secret Service agent Tim McCarthy. In 1989, a sharply divided Supreme Court ruled, in Texas v. Johnson, that burning the American flag as a form of political protest was protected by the First Amendment. In 1997, the WNBA made its debut as the New York Liberty defeated the host Los Angeles Sparks 67-57. In 2004, the aircraft SpaceShipOne made the first privately funded human spaceflight. In 2010, Faisal Shahzad, a Pakistan-born US citizen, pleaded guilty to charges of plotting a failed car bombing in New York's Times Square. (Shahzad was later sentenced to life in prison.)
Newsweek
an hour ago
- Newsweek
How Animal Testing in US Could Be Transformed Under Trump
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Millions of animals each year are killed in U.S. laboratories as part of medical training and chemical, food, drug and cosmetic testing, according to the non-profit animal rights organization People for the Ethical Treatment of Animals (PETA). For many animals held captive for research, including a huge range of species from dogs, cats and hamsters to elephants, dolphins and many other species, pain is "not minimized," U.S. Department of Agriculture data shows. The issue of animal testing is something most Americans agree on: it needs to change and gradually be stopped. A Morning Consult poll conducted at the end of last year found that 80 percent of the 2,205 participants either agreed or strongly agreed with the statement: "The US government should commit to a plan to phase out experiments on animals." Since President Donald Trump began his second term, his administration has been making moves to transform and reduce animal testing in country, although the question remains as to whether it will be enough to spare many more animals from pain and suffering this year. Animal Testing In US Could Be Transformed Animal Testing In US Could Be Transformed Photo-illustration by Newsweek/Getty/Canva What Is The Trump Administration Doing About It? There have been various steps taken in different federal agencies to tackle the issue of animal testing since Trump was sworn in on January 20. In April, the Food and Drug Administration (FDA) announced it was "taking a groundbreaking step to advance public health by replacing animal testing in the development of monoclonal antibody therapies and other drugs with more effective, human-relevant methods." The FDA said that its animal testing requirement will be "reduced, refined, or potentially replaced" with a range of approaches, including artificial intelligence-based models, known as New Approach Methodologies or NAMs data. A Department of Health and Human Services (HHS) official told Newsweek: "The agency is paving the way for faster, safer, and more cost-effective treatments for American patients. "As we restore the agency's commitment to gold-standard science and integrity, this shift will help accelerate cures, lower drug prices, and reaffirm U.S. leadership in ethical, modern science." The National Institutes of Health (NIH) announced it was "adopting a new initiative to expand innovative, human-based science while reducing animal use in research," in alignment with the FDA's initiative. The agency said that while "traditional animal models continue to be vital to advancing scientific knowledge," new and emerging technologies could act as alternative methods, either alone or in combination with animal models. The NIH Office of Extramural Research told Newsweek it was "committed to transparently assessing where animal use can be reduced or eliminated by transitioning to [new approach methodologies (NAMs)]." "Areas where research using animals is currently necessary represent high-priority opportunities for investment in NAMs," the agency added. It added that it will "further its efforts to coordinate agency-wide efforts to develop, validate, and scale the use of NAMs across the agency's biomedical research portfolio and facilitate interagency coordination and regulatory translation for public health protection." During Trump's first term, the Environmental Protection Agency (EPA) signed a directive to "prioritize efforts to reduce animal testing and committed to reducing testing on mammals by 30 percent by 2025 and to eliminate it completely by 2035," an EPA spokesperson told Newsweek. Although, the spokesperson added: "the Biden Administration halted progress on these efforts by delaying compliance deadlines." As a member of the House, Lee Zeldin, the EPA's current administrator, co-sponsored various bills during Trump's first term regarding animal cruelty, covering issues such as phasing out animal-based testing for cosmetic products; ending taxpayer funding for painful experiments on dogs at the Department of Veteran Affairs; empowering federal law enforcement to prosecute animal abuse cases that cross state lines; and others, the spokesperson said. What The Experts Think Needs To Be Done The Trump administration's efforts to tackle the issue of animal testing appear to be a step in the right direction, according to experts who spoke with Newsweek. "I was pleasantly surprised and quite frankly a bit shocked to read the simultaneous announcements by the NIH and the FDA regarding a new emphasis on the use of alternatives to animals," Jeffrey Morgan, a professor of pathology and laboratory medicine at Brown University in Rhode Island, told Newsweek. Morgan, who is also the director of the Center for Alternatives to Animals in Testing at Brown University, said that both agencies are moving together in the same direction on the issue "sends a unified and very powerful message to the research and biotech communities." He added that the announcements showed "a major acknowledgement of the limitations of the use of animals in research and testing." "What is especially exciting is that the NIH announcement will encourage the entry of new investigators into the field, further accelerating innovation in alternatives with exciting impacts for both discovery and applied research across all diseases," he said. He added that the FDA announcement and its emphasis on a new regulatory science that embraces data from alternatives was "equally exciting." "The demands of this new regulatory science will likewise accelerate innovation because it will establish the much-needed regulatory framework for the rigorous evaluation of data from alternatives," he said. While the administration's initiatives to shift research away from animal testing is heading in the right direction, its policies are "overdue," Dr. Thomas Hartung, a professor in the department of environmental health and engineering at Johns Hopkins Bloomberg School of Public Health, Maryland, told Newsweek. "The animal tests for safety were introduced more than 50 years ago. There is no other area of science where we do not adapt to scientific progress," he said. Hartung added that animal "testing takes too long and is too expensive to really provide the safety consumers want." He said that running animal tests for new chemicals can cost millions and take years in some cases. "Nobody can wait that long, even if they can afford the testing costs," he said. Hartung also believes the shifts in the industry to reduce animal testing have been "coming for a while," as over the last two decades, America's opposition to animal use in medical research has been increasing. "The alignment of FDA and NIH really makes the difference now, which I think is evidence of a strong relationship of their leaderships," he said. Yet in order to make a real difference, Hartung said clear deadlines are key to show that "this is not just lip service." He also said that he thought "the transformative nature of artificial intelligence in this field is not fully acknowledged." "We also need an objective framework for change to better science, such as the evidence-based toxicology approach," he said.
American Press
2 hours ago
- American Press
Columbia protester Mahmoud Khalil freed from immigration detention
Palestinian activist Mahmoud Khalil was released Friday from federal immigration detention, freed after 104 days by a judge's ruling after becoming a symbol of President Donald Trump 's clampdown on campus protests. The former Columbia University graduate student left a federal facility in Louisiana on Friday. He is expected to head to New York to reunite with his U.S. citizen wife and infant son, born while Khalil was detained. 'Justice prevailed, but it's very long overdue,' he said outside the facility in a remote part of Louisiana. 'This shouldn't have taken three months.' Email newsletter signup The Trump administration is seeking to deport Khalil over his role in pro-Palestinian protests. He was detained on March 8 at his apartment building in Manhattan. Khalil was released after U.S. District Judge Michael Farbiarz said it would be 'highly, highly unusual' for the government to continue detaining a legal U.S. resident who was unlikely to flee and hadn't been accused of any violence. 'Petitioner is not a flight risk, and the evidence presented is that he is not a danger to the community,' he said. 'Period, full stop.' During an hourlong hearing conducted by phone, the New Jersey-based judge said the government had 'clearly not met' the standards for detention. The government filed notice Friday evening that it's appealing Khalil's release. The Department of Homeland Security said in a post on the social platform X that the same day Farbiarz ordered Khalil's release, an immigration judge in Louisiana denied him bond and 'ordered him removed.' The decision was made by Judge Jamee Comans, who is in a court located in the same detention facility from which Khalil was released. 'An immigration judge, not a district judge, has the authority to decide if Mr. Khalil should be released or detained,' the post said. Khalil was the first person arrested under Trump's crackdown on students who joined campus protests against Israel's devastating war in Gaza. U.S. Secretary of State Marco Rubio has said Khalil must be expelled from the country because his continued presence could harm American foreign policy. The Trump administration has argued that noncitizens who participate in such demonstrations should be deported as it considers their views antisemitic. Protesters and civil rights groups say the administration is conflating antisemitism with criticism of Israel in order to silence dissent. Farbiarz has ruled that the government can't deport Khalil on the basis of its claims that his presence could undermine foreign policy. But the judge gave the administration leeway to continue pursuing a potential deportation based on allegations that he lied on his green card application, an accusation Khalil disputes. The international affairs graduate student isn't accused of breaking any laws during the protests at Columbia. He served as a negotiator and spokesperson for student activists and wasn't among the demonstrators arrested, but his prominence in news coverage and willingness to speak publicly made him a target of critics. The judge agreed Friday with Khalil's lawyers that the protester was being prevented from exercising his free speech and due process rights despite no obvious reason for his continued detention. The judge noted that Khalil is now clearly a public figure. Khalil said Friday that no one should be detained for protesting Israel's war in Gaza. He said his time in the Jena, Louisiana, detention facility had shown him 'a different reality about this country that supposedly champions human rights and liberty and justice.' 'Whether you are a U.S. citizen, an immigrant or just a person on this land doesn't mean that you are less of a human,' he said, adding that 'justice will prevail, no matter what this administration may try to portray' about immigrants. Khalil had to surrender his passport and can't travel internationally, but he will get his green card back and be given official documents permitting limited travel within the country, including New York and Michigan to visit family, New Jersey and Louisiana for court appearances and Washington to lobby Congress. In a statement after the judge's ruling, Khalil's wife, Dr. Noor Abdalla, said she can finally 'breathe a sigh of relief' after her husband's three months in detention. 'We know this ruling does not begin to address the injustices the Trump administration has brought upon our family, and so many others,' she said. 'But today we are celebrating Mahmoud coming back to New York to be reunited with our little family.' The judge's decision comes after several other scholars targeted for their activism have been released from custody, including another former Palestinian student at Columbia, Mohsen Mahdawi; a Tufts University student, Rumeysa Ozturk; and a Georgetown University scholar, Badar Khan Suri. ___ Marcelo reported from New York. Jennifer Peltz contributed from New York.
